New chemo approach may spare sinus cancer patients from major surgery
NCT ID NCT07320508
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is for people with a rare sinus cancer called sinonasal adenoid cystic carcinoma. The treatment delivers high-dose chemotherapy directly to the tumor through a small tube in an artery, aiming to shrink it as much as possible. After three sessions, doctors check if the tumor is gone; if so, patients get only radiation, avoiding major surgery. The goal is to see if this personalized approach is safe and effective.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADENOID CYSTIC CARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Eye and ENT Hospital, Fudan University
RECRUITINGShanghai, Xuhui Strict, 200031, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Experimental drug tazemetostat offered to patients with rare, aggressive tumors
- New drug cocktail targets genetic weakness in rare cancer
- Drug duo takes on rare head and neck tumors
- Rare sinus cancer study aims to clarify treatment outcomes
- New pill-chemo combo takes on hard-to-treat cancers
- New drug shows promise against rare salivary gland cancer